Pharmacogenetic Prediction of Metoprolol Effectiveness

NCT02293096 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

462

Enrollment

OTHER

Sponsor class

Stopped Study was terminated due to the change in funding.

Conditions

Hypertension

Interventions

DRUG: metoprolol succinate
GENETIC: Genotyping
PROCEDURE: CYP2D6 Phenotyping

Sponsor

University of Colorado, Denver

Collaborators

[object Object]